Clinical trials
Sepsis clinical trials
Below are recruiting sepsis clinical trials, each written for real people, not researchers. We’re tracking 268 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07040202Recruiting
Immune responses in dengue and sepsis patients
This study looks at how the immune system responds to dengue fever and sepsis (a severe infection). It aims to better understand these illnesses, which could lead to improved treatments. If you have dengue-like symptoms, sepsis, or are a healthy volunteer, you may be able to join.
Kampong SpeuAges 2 years+ - NCT07051694Recruiting
Ear nerve stimulation for sepsis patients in the ICU
This trial tests a non-invasive ear stimulation device (taVNS) as an extra treatment for sepsis in the ICU. It may help reduce inflammation and improve recovery.
ChongqingAges 18–80 - NCT07060560Recruiting
Presepsin blood test for severe burn sepsis diagnosis
This study tests a blood test called presepsin to see how well it detects sepsis in people with severe burns. If you have burns covering at least 20% of your body and your doctor suspects sepsis, this trial may help improve early diagnosis and treatment.
Seoul, SeoulAges 18 years+ - NCT07074028Recruiting
Tracking muscle changes in ICU patients with sepsis
This study is for people in the ICU with sepsis who need a breathing machine for a long time. It monitors muscle changes during recovery to understand how sepsis affects muscles.
Saint-BrieucAges 18 years+ - NCT07084129RecruitingPhase 1
Vancomycin and kidney injury study for children with sepsis
This trial tests a different way of giving vancomycin to children with sepsis to reduce the risk of kidney injury. It compares standard dosing to an approach that adjusts dose based on how the kidneys are working.
Philadelphia, PennsylvaniaAges 1 month–17 years - NCT07089524Recruiting
Comparing two blood tests for sepsis in ICUs
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
Cairo, AbbassiaAges 18–80 - NCT07126106Recruiting
Testing a computer program to find sepsis earlier in the ICU
This study tests a new computer program that helps doctors find serious infections (sepsis and bacteremia) earlier in ICU patients. If you join, the program will analyze your health data to see if it can better predict these infections, which could help you get faster treatment.
Seyrantepe, IstanbulAges 18 years+ - NCT07130799Recruiting
Monitoring immune response in severe abdominal infections with fungal risk
This trial monitors a marker of immune function (monocyte HLA-DR) in patients with severe abdominal infections that may lead to fungal infections. It aims to see if this marker can help guide treatment.
Vandœuvre-lès-NancyAges 18 years+ - NCT07152106Recruiting
Amniotic fluid and the preterm baby's gut
This study looks at the fluid around your baby (amniotic fluid) and how it might affect your baby's gut health if they are born early. It may help doctors understand how to better care for preterm infants.
AmsterdamAges 16 years+ - NCT07154615Recruiting
Immune system study in sepsis patients
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
Minneapolis, MinnesotaAges 18 years+ - NCT07172451RecruitingPhase 4
Gelaspan vs standard fluids for sepsis with belly infection
This trial tests whether a fluid called Gelaspan (a gelatin-based IV fluid) is better for treating sepsis patients who need emergency abdominal surgery than standard crystalloid fluids. It checks if you have a belly infection and high lactate levels, and you must not have serious heart, lung, or kidney problems.
Guangzhou, GuangdongAges 18 years+ - NCT07215702RecruitingPhase 2
Testing a drug for kidney injury from sepsis in the ICU
This trial tests if a new drug, AZD4144, can help people with sepsis-related acute kidney injury in the ICU. It aims to see if the drug can improve kidney recovery and reduce complications.
Tucson, ArizonaAges 18–80 - NCT07236463RecruitingPhase 1/Phase 2
Iron chelator in dialysis fluid for sepsis-related kidney injury
This trial tests if adding an iron chelator (MEX-CD1) to the dialysis fluid can help remove harmful iron from the blood in patients with sepsis-related acute kidney injury who need continuous dialysis. It may reduce damage to the kidneys and other organs.
Nîmes, GardAges 18 years+ - NCT07239713Recruiting
Comparing IV fluids for sepsis after abdominal surgery
This trial compares two types of intravenous fluids (Ringers Lactate vs. Sterofundin/Plasmalyte) to see which works better for sepsis after abdominal surgery. Sepsis is a serious infection that can affect the whole body. This study may help choose the best fluid for recovery.
Lahore, Punjab ProvinceAges 18–80 - NCT05875740Recruiting
Memory T cells and sepsis severity study
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
Wuhan, HubeiAges 18–60 - NCT07425587Recruiting
Symphony IL-6 test for sepsis in the emergency room
This trial checks if a new blood test (Symphony IL-6) can help doctors quickly identify sepsis in patients coming to the emergency room. It may speed up diagnosis and treatment for serious infections.
Gainesville, FloridaAges 22 years+ - NCT07273344Recruiting
How the immune system responds to sepsis
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
Nijmegen, GelderlandAges 18 years+ - NCT07342205RecruitingPhase 2/Phase 3
Fecal transplant for sepsis-related lung injury
This study tests if transferring healthy gut bacteria (fecal microbiota transplant) can help people with acute lung injury caused by sepsis. It aims to reduce inflammation and improve breathing.
Shanghai, PutuoAges 18 years+ - NCT07351344Recruiting
African survey on healthcare worker sepsis knowledge
This study uses an anonymous online survey to understand how healthcare workers in seven African countries recognize and manage sepsis. Your answers could help improve sepsis care across the continent.
KumasiAges 18 years+ - NCT01670383Recruiting
Study sample collection for sepsis and after cardiac arrest
This trial collects and stores small samples from people in the ICU who are either being treated for sepsis or who have survived a non-traumatic cardiac arrest. It may help researchers better understand how the body changes after severe infection or after revival, which could improve future care.
SeoulAges 16 years+ - NCT02936232Recruiting
Registry for severe sepsis and septic shock
This registry collects medical information from adults who have suspected or proven serious infection causing body organ problems. It helps researchers better understand what happens in severe sepsis and septic shock and may guide future care.
Seongnam-si, Gyeonggi-doAges 18 years+ - NCT07413094RecruitingPhase 2
Testing a new drug for sepsis-related lung injury
This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.
BeijingAges 18–75 - NCT07442552Recruiting
Studying sepsis risk after major abdominal surgery
This trial looks at genetic markers to better predict sepsis after major abdominal surgery. It may help find patients at higher risk so they can be treated earlier.
Bucharest, Sector 2Ages 18 years+ - NCT07454421Enrolling by invitationPhase 1/Phase 2
Racecadotril for organ injury in sepsis patients
This trial tests if Racecadotril, a medication that may protect organs from damage, can help people with sepsis (a severe infection that affects the whole body). It is for patients who are in the hospital and have a certain level of organ injury.
Guanzhou, GuangdongAges 18–80
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for sepsis?
- Yes. Clin2 currently lists 268 recruiting sepsis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a sepsis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a sepsis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.